Marsh & McLennan Companies (MMC)
(Delayed Data from NYSE)
$221.25 USD
+0.20 (0.09%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $221.26 +0.01 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$221.25 USD
+0.20 (0.09%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $221.26 +0.01 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth B Momentum D VGM
Zacks News
Marsh & McLennan (MMC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Marsh & McLennan (MMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Marsh & McLennan (MMC) Arm Acquires to Boost Its Portfolio
by Zacks Equity Research
Marsh & McLennan (MMC) purchases the leading brokerage firm Ironwood Insurance to enrich its portfolio.
Marsh & McLennan Unit Allies With LIFT for Digital Wellness
by Zacks Equity Research
Marsh & McLennan's (MMC) arm collaborates with LIFT session to offer a customized digital fitness program in Canadian offices.
Why Is Marsh & McLennan (MMC) Up 4.7% Since Last Earnings Report?
by Zacks Equity Research
Marsh & McLennan (MMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Insurance Brokerage Outlook Sanguine on M&As, Rising Rates
by Sapna Bagaria
Mergers and acquisitions, increasing premium rates, and investments in technology bode well for the insurance brokerage industry.
Aon to Buy CoverWallet for Serving Small to Medium Businesses
by Zacks Equity Research
Aon (AON) will acquire CoverWallet to access the rapidly-evolving digital insurance market for small and medium-sized businesses.
Marsh & McLennan Hits 52-Week: Will It Continue to Rise?
by Zacks Equity Research
Marsh & McLennan (MMC) touches a 52-week high, backed by consistent operating performance.
Why Earnings Season Could Be Great for Marsh & McLennan (MMC)
by Zacks Equity Research
Marsh & McLennan (MMC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Marsh & McLennan's (MMC) Q3 Earnings Surpass, Decline Y/Y
by Zacks Equity Research
Marsh & McLennan's (MMC) third-quarter results benefit from solid revenues.
Marsh & McLennan (MMC) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 11.59% and -0.83%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Willis Towers (WLTW) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Improved performance across Willis Towers' (WLTW) segments is expected to get reflected in its Q3 results.
Is a Beat in Store for Marsh & McLennan's (MMC) Q3 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) third-quarter results are likely to be hurt by elevated debt levels and its weak Risk & Insurance services business, partly offset by solid revenues.
Why Marsh & McLennan (MMC) Could Beat Earnings Estimates Again
by Zacks Equity Research
Marsh & McLennan (MMC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
What's in the Cards for Aon (AON) This Earnings Season?
by Zacks Equity Research
Aon (AON) is likely to have benefited from strong segmental performances in Q3, partly offset by high interest expenses.
What's in Store for Arthur J. Gallagher (AJG) in Q3 Earnings?
by Zacks Equity Research
Arthur J. Gallagher (AJG) Q3 earnings are likely to have benefited from organic sales and better pricing.
Marsh & McLennan's Unit Ties Up for Pet Insurance Program
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary Marsh partners Zurich North America to launch a pet insurance program.
The Zacks Analyst Blog Highlights: Nvidia, Ford, Marsh & McLennan, American Electric and TransUnion
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nvidia, Ford, Marsh & McLennan, American Electric and TransUnion
Top Research Reports for Nvidia, Ford and Marsh & McLennan
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA (NVDA), Ford Motor (F) and Marsh & McLennan Companies (MMC).
Marsh & McLennan Arm to Pilot Digital Placement Platform
by Zacks Equity Research
Marsh & McLennan's (MMC) Marsh subsidiary to pilot a blockchain-enabled digital platform to ease the insurance placement procedure.
Marsh & McLennan, Xevant Tie Up to Ease Employer Assistance
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary collaborates with Xevant to offer a strategic optimization solution for employer-funded pharmacy benefit plans.
Marsh & McLennan's Unit Joins Next Peak for Cyber Protection
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary Oliver Wyman teams up with Next Peak to safeguard against cyber risks.
Marsh & McLennan Inks Deal With Construction Risk Partners
by Zacks Equity Research
Marsh & McLennan (MMC) reaches an agreement with Construction Risk Partners, according to which the latter will buy the company's stock from JLT.
Why You Should Keep Marsh & McLennan (MMC) in Your Portfolio
by Zacks Equity Research
Banking on strategic acquisitions and financial flexibility, Marsh & McLennan (MMC) holds enough potential to reap benefits for investors.
Marsh & McLennan (MMC) Down 1.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Marsh & McLennan (MMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Caterpillar, Walmart, McDonald's, Pfizer and Marsh & McLennan
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Caterpillar, Walmart, McDonald's, Pfizer and Marsh & McLennan